A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705
2010 ◽
Vol 5
(1)
◽
pp. 99-104
◽
Hiroshige Yoshioka
◽
Katsuyuki Hotta
◽
Katsuyuki Kiura
◽
Nagio Takigawa
◽
Hidetoshi Hayashi
◽
...
2018 ◽
Vol 82
(6)
◽
pp. 1031-1038
◽
Naohiro Oda
◽
Kastuyuki Hotta
◽
Kiichiro Ninomiya
◽
Daisuke Minami
◽
Eiki Ichihara
◽
...
2018 ◽
Vol 115
◽
pp. 103-108
◽
Takashi Ninomiya
◽
Naoyuki Nogami
◽
Toshiyuki Kozuki
◽
Daijiro Harada
◽
Toshio Kubo
◽
...
2015 ◽
Vol 89
(1)
◽
pp. 61-65
◽
Akira Inoue
◽
Shunichi Sugawara
◽
Makoto Maemondo
◽
Yoshiaki Mori
◽
Satoshi Oizumi
◽
...
2017 ◽
Vol 28
◽
pp. x139-x140
A. Bessho
◽
N. Ochi
◽
S. Kuyama
◽
T. Umeno
◽
G. Ikeda
◽
...
2005 ◽
Vol 129
(5)
◽
pp. 977-983
◽
Ryosuke Tsuchiya
◽
Kenji Suzuki
◽
Yukito Ichinose
◽
Yoh Watanabe
◽
Tsutomu Yasumitsu
◽
...
2009 ◽
Vol 7
(2)
◽
pp. 526
M. Maemondo
◽
O. Ishimoto
◽
A. Inoue
◽
N. Matsubara
◽
N. Morikawa
◽
...
2012 ◽
Vol 23
◽
pp. xi115
N. Nogami
◽
T. Kozuki
◽
Y. Segawa
◽
T. Shinkai
◽
T. Maeda
◽
...
2010 ◽
Vol 21
(4)
◽
pp. 800-803
◽
A. Inoue
◽
O. Ishimoto
◽
S. Fukumoto
◽
K. Usui
◽
T. Suzuki
◽
...
Close
Export Citation Format
Close
Share Document
Close